These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 3226945)

  • 1. [Synergistic effects of davercin, rifampicin, ethambutol and isonicotinic acid hydrazide on selected standard strains of Mycobacterium in the in-vitro and in-vivo experiments].
    Janowiec M; Andrzejczyk Z; Szwedowicz I
    Pneumonol Pol; 1988 Jun; 56(6):278-82. PubMed ID: 3226945
    [No Abstract]   [Full Text] [Related]  

  • 2. [Combination of gentamycin and amikacin with rifampicin, ethambutol and isoniazid on selected standard strains of Mycobacterium species in experiments done in vitro and in vivo].
    Janowiec M; Andrzejczyk Z; Marczewska J
    Pneumonol Pol; 1989 May; 57(5):300-7. PubMed ID: 2633149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycobacterium fortuitum infections: a review with two illustrative cases.
    Halpern AA; Nagel DA
    Clin Orthop Relat Res; 1978 Oct; (136):247-52. PubMed ID: 729293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The "in vitro" activity of rifampicin compared with ethambutol, capreomycin and isoniazid.
    Steinbrück PW
    Acta Tuberc Pneumol Belg; 1969; 60(3):413-6. PubMed ID: 4984421
    [No Abstract]   [Full Text] [Related]  

  • 5. [Chemotherapeutic regimens for nontuberculous mycobacterial infection based on in-vitro susceptibility test results].
    Tsukamura M; Yamori S
    Kekkaku; 1990 May; 65(5):349-57. PubMed ID: 2168003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experimental study of 2d order tuberculostatic preparations in Mycobacterium bovis resistance to isoniazid or streptomycin (based on the data from a morphological study)].
    Golyshevskaia VI; El'shanskaia MP
    Farmakol Toksikol; 1975; 38(2):222-4. PubMed ID: 776650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intra-macrophagic activity of antibiotics combinations against Mycobacterium marinum].
    Gevaudan MJ; Bollet C; Mallet MN; de Micco P
    Pathol Biol (Paris); 1991 May; 39(5):436-41. PubMed ID: 1652732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between the in vitro drug susceptibility of opportunist mycobacteria and their in vivo response to treatment.
    Heginbothom ML
    Int J Tuberc Lung Dis; 2001 Jun; 5(6):539-45. PubMed ID: 11409581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experimental in-vitro and in-vivo studies of the antibacterial effect of rifampicin and ethambutol].
    Kozulicyna TI; Korotajev GA
    G Ital Chemioter; 1972; 19(2):7-10. PubMed ID: 4199030
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro synergistic activity of ethambutol, isoniazid, kanamycin, rifampin, and streptomycin against Mycobacterium avium-intracellulare complex.
    Zimmer BL; DeYoung DR; Roberts GD
    Antimicrob Agents Chemother; 1982 Jul; 22(1):148-50. PubMed ID: 7125626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interactions of antitubercular drugs. II. Combined effects of rifampin, ethambutol, capreomycin, viomycin, ethionamide and cycloserine on mycobacterial growth in vitro].
    Janowiec M; Zwolska-Kwiek Z
    Pneumonol Pol; 1983 Dec; 51(12):607-12. PubMed ID: 6199778
    [No Abstract]   [Full Text] [Related]  

  • 12. Atypical mycobacteriosis of the urinary tract. A case report of extensive disease caused by the Battey bacillus.
    Pergament M; Gonzalez R; Fraley EE
    JAMA; 1974 Aug; 229(7):816-7. PubMed ID: 4407865
    [No Abstract]   [Full Text] [Related]  

  • 13. Mode of action of antituberculous agents and ultrastructure of mycobacteria.
    Oka S; Yamaguchi J; Ariji F; Madokoro K; Kumano N
    Sci Rep Res Inst Tohoku Univ Med; 1971 Jul; 18(1):7-13. PubMed ID: 5005200
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug resistance in tuberculosis in Delhi: a 2 year profile (2001--2002).
    Negi SS; Gupta S; Lal S
    J Commun Dis; 2003 Jun; 35(2):74-81. PubMed ID: 15562952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Determination of resistance of Mycobacterium tuberculosis against isonicotinic acid hydrazide, streptomycin, para-aminosalicylic acid, ethionamide, ethambutol and rifampicin using the 32 P incorporation test].
    Reutgen H
    Acta Biol Med Ger; 1973; 30(3):309-16. PubMed ID: 4202698
    [No Abstract]   [Full Text] [Related]  

  • 16. [Quality control of culture media for mycobacterium drug sensitivity tests].
    Kekkaku; 2003 Aug; 78(8):563-8. PubMed ID: 14582504
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of iron loading on the activity of isoniazid or ethambutol in the treatment of murine tuberculosis.
    Lounis N; Maslo C; Truffot-Pernot C; Grosset J; Boelaert RJ
    Int J Tuberc Lung Dis; 2003 Jun; 7(6):575-9. PubMed ID: 12797701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulfamethoxazole enhances the antimycobacterial activity of rifampicin.
    Macingwana L; Baker B; Ngwane AH; Harper C; Cotton MF; Hesseling A; Diacon AH; van Helden P; Wiid I
    J Antimicrob Chemother; 2012 Dec; 67(12):2908-11. PubMed ID: 22875849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)].
    Smirnova TG; Chernousova LN; Andreevskaia SN; Nikolaeva GM
    Probl Tuberk Bolezn Legk; 2004; (3):32-7. PubMed ID: 15338898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-course treatment regimens for patients with tuberculosis.
    Dutt AK; Stead WW
    Arch Intern Med; 1980 Jun; 140(6):827-9. PubMed ID: 6770770
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.